Literature DB >> 2376396

Attenuated cells in breast stroma: the missing lymphatic system of the breast.

E Hartveit1.   

Abstract

The breast stroma, in association with normal and neoplastic epithelium, is shown to contain cells of similar ultrastructure to the fine lymphatic vessels and sinusoids described in detail in the literature on other organs. As in other organs, the lumen of these structures is in continuity with the tissue spaces, allowing a free flow of lymph and its content, fluid and cells, from the tissues to the drainage system. The lymphatic system is, thus, open-ended-the endothelial cells of its finest branches having overlapping junctions that open passively on demand. There is, therefore, no need to postulate that cancer cells actively invade the surrounding tissues. In addition, the breast stroma contains endothelial cells in which the luminal side is not apposed to that of the same or another endothelial cell. These, like other endothelial cells, are attached to the connective tissue elements on one side only. It is suggested that they provide a series of potential spaces that can conduct fluid rapidly through the tissues, providing the epithelial cells with a copious supply of nutrients. This irrigation system is termed the lymphatic labyrinth, to distinguish it from the classical sinusoids and collecting vessels of the drainage system.

Entities:  

Mesh:

Year:  1990        PMID: 2376396     DOI: 10.1111/j.1365-2559.1990.tb01158.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

2.  Pseudoangiomatous spindle cell lipoma with "true" angiomatous features.

Authors:  M Zamecnik
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

3.  The pre-lymphatic pathway, the rooths of the lymphatic system in breast tissue: a 3D study.

Authors:  Sofia Asioli; Vincenzo Eusebi; Laura Gaetano; Luisa Losi; Gianni Bussolati
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

4.  Breast cancer metastasis and the lymphatic system.

Authors:  Munazzah Rahman; Sulma Mohammed
Journal:  Oncol Lett       Date:  2015-07-13       Impact factor: 2.967

5.  Incomplete inside-out growth pattern in invasive breast carcinoma: association with lymph vessel invasion and recurrence-free survival.

Authors:  Sayaka Kuba; Hiroshi Ohtani; Junzo Yamaguchi; Hiroko Hayashi; Tatsuya Uga; Takashi Kanematsu; Isao Shimokawa
Journal:  Virchows Arch       Date:  2011-01-08       Impact factor: 4.064

6.  Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.

Authors:  M Skobe; L M Hamberg; T Hawighorst; M Schirner; G L Wolf; K Alitalo; M Detmar
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

7.  LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.

Authors:  M I Koukourakis; A Giatromanolaki; E Sivridis; C Simopoulos; K C Gatter; A L Harris; D G Jackson
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

8.  Pseudoangiomatous stromal hyperplasia: An observation on its microscopic involvement in breast carcinoma and the presence of lymph node metastases.

Authors:  John D Coyne
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

9.  A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity.

Authors:  T Kato; R Prevo; G Steers; H Roberts; R D Leek; T Kimura; S Kameoka; T Nishikawa; M Kobayashi; D G Jackson; A L Harris; K C Gatter; F Pezzella
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

Review 10.  Lymphatic endothelium: morphological, molecular and functional properties.

Authors:  Michael S Pepper; Mihaela Skobe
Journal:  J Cell Biol       Date:  2003-10-27       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.